英文名稱 | Anti-Human CD3xCEACAM5 Bispecific Antibody(Cibisatamab) |
---|---|
中文名稱 | 賽必妥單抗 |
CAS號(hào) | 2101242-53-7 |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無牌價(jià)信息,您可以發(fā)送詢價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱 | Anti-Human CD3xCEACAM5 Bispecific Antibody(Cibisatamab) |
---|---|
中文名稱 | 賽必妥單抗 |
CAS號(hào) | 2101242-53-7 |
Cibisatamab is a T-cell bispecific antibody designed to target carcinoembryonic antigen (CEA) on tumor cells and CD3 on T cells, activating T cells to selectively eliminate CEA-expressing tumors. This humanized antibody has a 2:1 molecular format, enhancing CEA avidity for effective tumor cell targeting. Cibisatamab (CEA-TCB) can be used for colorectal cancer research.
PMID: 30982469 PMCID: PMC6463631 DOI: 10.1186/s40425-019-0575-3